NCT06637124

Brief Summary

This clinical trail will be conducted to investigate the effect of blood flow restriction (BFR) with different load levels between low blood occlusion percentage (50%) group and high blood occlusion percentage (70%) compared to moderate intensity training (60% of 1 RM) in patients with chronic knee osteoarthritis. The main questions it aims to answer are:

  1. 1.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on pain intensity in knee osteoarthritis ?
  2. 2.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on quadriceps muscle strength in knee osteoarthritis ?
  3. 3.Will there be no difference difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on rate of perceived exertion in knee osteoarthritis ?
  4. 4.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on functional ability in knee osteoarthritis ?
  5. 5.Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on physical function in knee osteoarthritis ?
  6. 6.16 sessions of supervised intervention 2 times per week for 8 weeks.
  7. 7.The assessment will be at 3 time points, baseline and at 4 weeks and at 8 weeks.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Oct 2024

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2025

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2026

Completed
Last Updated

May 6, 2026

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

September 24, 2024

Last Update Submit

May 2, 2026

Conditions

Keywords

Blood Flow RestrictionKnee osteoarthritisModerate Intenstity Exercise

Outcome Measures

Primary Outcomes (2)

  • Change in pain intensity

    Measured by the Visual Analog Scale (VAS)which is a pain intensity assessment tool. * Represented with a 10 cm line with 0 indicating no pain and on the other end 10 indicating severe pain. * The patient is asked to move a marker on the line to the position which best describes their pain. * That it will serve as a subjective measure of their current level of knee pain intensity. The closer the mark to zero is better.

    Measured 3 times at basline, 4 weeks and 8 weeks

  • Measure change in quadriceps muscle strength

    Hand-held dynamometer (HHD) will be used to measure the strength in quadriceps muscle. * The maximum force or pressure exerted by the quadriceps muscle during the contraction will be recorded. * Typically, this measurement is expressed in kilograms (kg) and then transferred to Newtons (N) * To enhance reliability, 3 trials may be conducted, and average will be taken to obtain a more representative measurement of muscle strength. * The higher the measurement the higher the muscle strength.

    Measured 3 times at baseline, 4 weeks and 8 weeks

Secondary Outcomes (3)

  • Change in functional ability

    Measured 3 times at baseline, 4 weeks and 8 weeks

  • Change in physical function levels

    Measured 3 times at baseline, 4 weeks and 8 weeks

  • Change in Rate of perceived exertion scale (RPE)

    Measured 3 times at basline , 4 weeks and 8 weeks

Study Arms (3)

50% Blood Flow Restriction Group

EXPERIMENTAL

The Blood Flow Restriction device will be set to restrict blood flow at level of 50% of arterial occlusion pressure at rest. Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.

Device: Blood Flow Restriction Therapy Device

70% Blood Flow Restriction Group

EXPERIMENTAL

The Blood Flow Restriction device will be set to restrict blood flow at level of 70% of arterial occlusion pressure at rest. Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.

Device: Blood Flow Restriction Therapy Device

Moderate Intensity Exercise training Group

ACTIVE COMPARATOR

Patients assigned to this group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) for a total of 16 treatment sessions according to exercise guidelines for seniors with OA. MIRT protocols consists of 3 sets for every exercise, 12 repetitions per set, rest period between sets 2 mins, 2 session per week for 8 weeks. Resistance exercises will be performed using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.

Device: 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.

Interventions

Blood Flow Restriction (BFR) therapy involves units use standardized cuffs of varying widths and lengths which are physically attached to the devices and provide the capability of precisely controlling the amount of pressure applied to each limb during exercise or at rest. We will be using Smart Cuffs® 4.0 which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it will calculate and set the optimal pressure for each participant's limb. There is no need for an external doppler probe or hand pump. Made in the USA, SmartCuffs® are registered with the FDA as a Class 1 Medical Device. Blood flow restriction therapy is commonly paired with resistive training, so this study will explore the effect of blood flow restriction at rest for patients with osteoarthritis at different restriction levels (50% for first group and 70% for second group).

Also known as: Smart cuffs 4.0
50% Blood Flow Restriction Group70% Blood Flow Restriction Group

Patients assigned to group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.

Moderate Intensity Exercise training Group

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with chronic knee osteoarthritis referred by orthopedic surgeons participants of both genders age are 40-65.
  • Patients with grade 2 and 3 OA of the knee, according to radiologic evaluation
  • If both knees diagnosed as OA, the most affected one will be selected.
  • Diagnosis of Knee OA who had knee pain and functional disabilities for at least three months, according to American College of Rheumatology classification at screening visit.
  • Visual Analogue Scale (VAS) at rest score of ≥40 mm.
  • Arabic version of the western WOMAC (ArWOMAC) scores (average 37).
  • Moderate Physical activity score on the IPAQ (between 3.0 and 7.9 METS).

You may not qualify if:

  • Moderate to significant knee synovitis
  • Hot or red knee
  • History and/or physical examination findings compatible with the internal derangement of knee.
  • Knee pain that is initiated or increased with knee activity/exercise and finished or decreased with knee resting.
  • Other muscular, articular, or neurological condition affecting lower limb function.
  • Patients with any previous knee surgeries or fractures of lower limb
  • Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months.
  • Psychological or psychiatric disorders that may affect a subject's participation in the study.
  • Participants with congenital musculoskeletal lower limb deformity.
  • Participated in other intervention studies on the past 6 months to screening
  • Participants with contraindications to blood flow Restriction Training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CairoU

Cairo, Giza Governorate, 12611, Egypt

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Lecturer

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Masters Degree Student in Faculty of Physical Therapy, Cairo University

Study Record Dates

First Submitted

September 24, 2024

First Posted

October 15, 2024

Study Start

October 15, 2024

Primary Completion

February 26, 2025

Study Completion

May 6, 2026

Last Updated

May 6, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

* The risk that sharing prevents the exploitation of the entire potential of the data obtained. * Possible failures in patients' privacy protection. * Technical barriers such as the lack of standard formats and possible data misinterpretation. * Issues regarding data ownership. * Reuse of data for unfair commercial purposes.

Locations